{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:49:31Z","timestamp":1793922571460,"version":"4.8.0"},"reference-count":31,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:sec id=\"ab-hoi260043-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Patients undergoing aortic valve replacement (AVR) for chronic severe aortic regurgitation (AR) based on current guideline-based thresholds may have irreversible myocardial scarring.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-hoi260043-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To quantify reverse remodeling, functional recovery, and symptomatic change after AVR and assess whether myocardial fibrosis is associated with incomplete recovery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-hoi260043-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>In this prospective longitudinal observational study, patients with chronic severe AR referred for AVR by a cardiology team were included. Key exclusion criteria were previous valve surgery, moderate or greater valve disease, and other primary cardiomyopathies. Included patients underwent paired biomarkers, echocardiography, cardiopulmonary exercise testing, and cardiovascular magnetic resonance (CMR) at baseline and at a median of 7 months after AVR. The study took place at 2 tertiary cardiothoracic centers in London, United Kingdom, with enrollment from August 2021 to October 2023. Data were analyzed from January to April 2026.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-hoi260043-7\">\n                    <jats:title>Exposure<\/jats:title>\n                    <jats:p>AVR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-hoi260043-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Left ventricular (LV) reverse remodeling (change in LV end-diastolic volume [LVEDV] and LV mass) post-AVR and preoperative correlates of incomplete recovery, with prespecified focus on CMR fibrosis markers (late gadolinium enhancement [LGE] and extracellular volume [ECV]).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-hoi260043-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Seventy-two patients (median [IQR] age, 60 [6-70] years; 59 [82%] male, 35 [49%] with bicuspid aortic valve) completed paired studies. Median (IQR) regurgitant volume fell from 61 (38-83) mL to 5 (3-8) mL; median (IQR) LVEDV fell 44% from 273 (211-307) mL to 153 (130-177) mL; and median (IQR) LV mass fell 21% from 200 (159-226) g to 158 (137-184) g (all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001). Indexed intracellular volume declined 21% and indexed extracellular volume 15% (26 mL\/m\n                      <jats:sup>2<\/jats:sup>\n                      to 22 mL\/m\n                      <jats:sup>2<\/jats:sup>\n                      ;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001), raising extracellular volume fraction (ECV%) from 27.4% to 29.1% (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001). LGE as a percentage of LV mass was unchanged (2.3% to 2.4%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.36); baseline LGE burden was associated with less regression of LV mass (\u03c7\n                      <jats:sup>2<\/jats:sup>\n                      <jats:sub>2<\/jats:sub>\n                      \u2009=\u200929.4;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001) and LVEDV at 7 months (\u03c7\n                      <jats:sup>2<\/jats:sup>\n                      <jats:sub>1<\/jats:sub>\n                      \u2009=\u20097.9;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.007). New York Heart Association class and quality of life improved (median [IQR] EQ-5D index improved from 0.89 [0.78-1.00] to 0.94 [0.81-1.00];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001), but maximum oxygen consumption was unchanged (22.6 mL\/kg\/min to 21 mL\/kg\/min;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.08). N-terminal pro\u2013B-type natriuretic peptide decreased slightly (228 pg\/mL to 198 pg\/mL;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.27), with a larger fall in patients with evidence of decompensation (n\u2009=\u200931; 469 pg\/mL to 279 pg\/mL;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.02).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-hoi260043-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this study, AVR was associated with substantial reverse remodeling at 7 months, including regression of hypertrophy and a fall in indexed extracellular (matrix) volume; the extracellular volume fraction rose, as cellular regression outpaced matrix regression. Focal scar, as a proportion of myocardium, was unchanged. Preoperative focal scar was independently associated with less recovery and may mark incomplete remodeling. Objective functional recovery did not improve at this time point.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamacardio.2026.3204","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:30:29Z","timestamp":1787758229000},"page":"981","source":"Crossref","is-referenced-by-count":2,"title":["Myocardial Fibrosis and Reverse Remodeling After Valve Replacement in Chronic Aortic Regurgitation"],"prefix":"10.1001","volume":"11","author":[{"given":"George D.","family":"Thornton","sequence":"first","affiliation":[{"name":"Institute of Cardiovascular Science, University College London, London, United Kingdom"},{"name":"St Bartholomew\u2019s Hospital, Barts Health National Health Service Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan B.","family":"Bennett","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Science, University College London, London, United Kingdom"},{"name":"St Bartholomew\u2019s Hospital, Barts Health National Health Service Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikoo","family":"Aziminia","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Science, University College London, London, United Kingdom"},{"name":"St Bartholomew\u2019s Hospital, Barts Health National Health Service Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leire","family":"Tapia","sequence":"additional","affiliation":[{"name":"Program of Cardiovascular Disease, Centro de Investigaci\u00f3n M\u00e9dica Aplicada, Universidad de Navarra, Department of Cardiology and Cardiac Surgery, Cl\u00ednica Universidad de Navarra and Instituto de Investigaci\u00f3n Sanitaria de Navarra, Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Birkinshaw","sequence":"additional","affiliation":[{"name":"King\u2019s College Hospital, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"McKenna","sequence":"additional","affiliation":[{"name":"St Vincent\u2019s University Hospital, Elm Park, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain","family":"Pierce","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Science, University College London, London, United Kingdom"},{"name":"St Bartholomew\u2019s Hospital, Barts Health National Health Service Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Batay","sequence":"additional","affiliation":[{"name":"St Bartholomew\u2019s Hospital, Barts Health National Health Service Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanelle","family":"Generoso","sequence":"additional","affiliation":[{"name":"St Bartholomew\u2019s Hospital, Barts Health National Health Service Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Bhattacharyya","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Science, University College London, London, United Kingdom"},{"name":"St Bartholomew\u2019s Hospital, Barts Health National Health Service Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Lloyd","sequence":"additional","affiliation":[{"name":"St Bartholomew\u2019s Hospital, Barts Health National Health Service Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Sado","sequence":"additional","affiliation":[{"name":"King\u2019s College Hospital, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kellman","sequence":"additional","affiliation":[{"name":"National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arantxa","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Program of Cardiovascular Disease, Centro de Investigaci\u00f3n M\u00e9dica Aplicada, Universidad de Navarra, Department of Cardiology and Cardiac Surgery, Cl\u00ednica Universidad de Navarra and Instituto de Investigaci\u00f3n Sanitaria de Navarra, Pamplona, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Enfermedades Cardiovasculares, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Moon","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Science, University College London, London, United Kingdom"},{"name":"St Bartholomew\u2019s Hospital, Barts Health National Health Service Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Treibel","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Science, University College London, London, United Kingdom"},{"name":"St Bartholomew\u2019s Hospital, Barts Health National Health Service Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Barts Valve Team Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aderonke T","family":"Abiodun","sequence":"additional","affiliation":[{"name":"for the Barts Valve Team Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shavisa","family":"Akavuthivanich","sequence":"additional","affiliation":[{"name":"for the Barts Valve Team Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhodri H","family":"Davies","sequence":"additional","affiliation":[{"name":"for the Barts Valve Team Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Gautam-Aitken","sequence":"additional","affiliation":[{"name":"for the Barts Valve Team Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Nitsche","sequence":"additional","affiliation":[{"name":"for the Barts Valve Team Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Shetye","sequence":"additional","affiliation":[{"name":"for the Barts Valve Team Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma","family":"Abdullahi","sequence":"additional","affiliation":[{"name":"for the Barts Valve Team Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Adams","sequence":"additional","affiliation":[{"name":"for the Barts Valve Team Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirish","family":"Ambekar","sequence":"additional","affiliation":[{"name":"for the Barts Valve Team Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dincer","family":"Aktuerk","sequence":"additional","affiliation":[{"name":"for the Barts Valve Team Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael","family":"Awad","sequence":"additional","affiliation":[{"name":"for the Barts Valve Team Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sveeta","family":"Badiani","sequence":"additional","affiliation":[{"name":"for the Barts Valve Team Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo","family":"Di Salvo","sequence":"additional","affiliation":[{"name":"for the Barts Valve Team Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"de la Cruz","sequence":"additional","affiliation":[{"name":"for the Barts Valve Team Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Gama","sequence":"additional","affiliation":[{"name":"for the Barts Valve Team Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyamsunder","family":"Kolvekar","sequence":"additional","affiliation":[{"name":"for the Barts Valve Team Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kulvinder","family":"Lall","sequence":"additional","affiliation":[{"name":"for the Barts Valve Team Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lawrence","sequence":"additional","affiliation":[{"name":"for the Barts Valve Team Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Lopez-Marco","sequence":"additional","affiliation":[{"name":"for the Barts Valve Team Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aung","family":"Oo","sequence":"additional","affiliation":[{"name":"for the Barts Valve Team Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Roberts","sequence":"additional","affiliation":[{"name":"for the Barts Valve Team Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Sheikh","sequence":"additional","affiliation":[{"name":"for the Barts Valve Team Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Shipolini","sequence":"additional","affiliation":[{"name":"for the Barts Valve Team Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Sulaiman","sequence":"additional","affiliation":[{"name":"for the Barts Valve Team Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Uppal","sequence":"additional","affiliation":[{"name":"for the Barts Valve Team Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phooi Kit","family":"Wong","sequence":"additional","affiliation":[{"name":"for the Barts Valve Team Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Yates","sequence":"additional","affiliation":[{"name":"for the Barts Valve Team Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Yap","sequence":"additional","affiliation":[{"name":"for the Barts Valve Team Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Garg","sequence":"additional","affiliation":[{"name":"for the Barts Valve Team Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"5","key":"hoi260043r1","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1161\/CIR.0000000000000923","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"issue":"7","key":"hoi260043r2","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"ESC\/EACTS guidelines for the management of valvular heart disease: developed by the task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).","volume":"43","author":"Vahanian","year":"2021","journal-title":"Eur Heart J"},{"issue":"11 pt 1","key":"hoi260043r3","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1016\/j.jcmg.2018.11.022","article-title":"Do guideline-based indications result in an outcome penalty for patients with severe aortic regurgitation?","volume":"12","author":"de Meester","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"hoi260043r4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12968-017-0389-8","article-title":"Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI).","volume":"19","author":"Messroghli","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"issue":"8","key":"hoi260043r5","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.jacc.2017.12.035","article-title":"Reverse myocardial remodeling following valve replacement in patients with aortic stenosis.","volume":"71","author":"Treibel","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"hoi260043r6","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1161\/CIRCULATIONAHA.117.032839","article-title":"Myocardial scar and mortality in severe aortic stenosis.","volume":"138","author":"Musa","year":"2018","journal-title":"Circulation"},{"issue":"3","key":"hoi260043r7","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.jacc.2019.11.032","article-title":"Extracellular myocardial volume in patients with aortic stenosis.","volume":"75","author":"Everett","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"hoi260043r8","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.018731","article-title":"Myocardial scar and mortality in chronic aortic regurgitation.","volume":"9","author":"Malahfji","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"hoi260043r9","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1016\/j.jcmg.2021.04.028","article-title":"Regional replacement and diffuse interstitial fibrosis in aortic regurgitation: prognostic implications from cardiac magnetic resonance.","volume":"14","author":"Senapati","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"issue":"7","key":"hoi260043r10","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1093\/ehjci\/jead041","article-title":"Postoperative myocardial fibrosis assessment in aortic valvular heart diseases-a cardiovascular magnetic resonance study.","volume":"24","author":"Pires","year":"2023","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"7","key":"hoi260043r11","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/ehjci\/jet105","article-title":"Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging.","volume":"14","author":"Lancellotti","year":"2013","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"4","key":"hoi260043r12","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.echo.2017.01.007","article-title":"Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance.","volume":"30","author":"Zoghbi","year":"2017","journal-title":"J Am Soc Echocardiogr"},{"issue":"1","key":"hoi260043r13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1532-429X-15-92","article-title":"Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement.","volume":"15","author":"Moon","year":"2013","journal-title":"J Cardiovasc Magn Reson"},{"issue":"10","key":"hoi260043r14","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L).","volume":"20","author":"Herdman","year":"2011","journal-title":"Qual Life Res"},{"issue":"4","key":"hoi260043r15","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1161\/STROKEAHA.121.034859","article-title":"National Institutes of Health Stroke Scale as an outcome in stroke research: value of ANCOVA over analyzing change from baseline.","volume":"53","author":"Mistry","year":"2022","journal-title":"Stroke"},{"issue":"3","key":"hoi260043r17","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1080\/10976640600572889","article-title":"Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance.","volume":"8","author":"Maceira","year":"2006","journal-title":"J Cardiovasc Magn Reson"},{"issue":"10","key":"hoi260043r18","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1016\/j.jcmg.2022.05.006","article-title":"Differences in cardiac remodeling in left-sided valvular regurgitation: implications for optimal definition of significant aortic regurgitation.","volume":"15","author":"Vejpongsa","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"hoi260043r19","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s10554-025-03566-9","article-title":"Quantitative cardiac MRI assessment of aortic regurgitation and reverse remodeling after surgery: a multi-center study.","volume":"42","author":"Malahfji","year":"2025","journal-title":"Int J Cardiovasc Imaging"},{"issue":"6","key":"hoi260043r20","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s10554-023-02811-3","article-title":"Association between ECG parameters and late gadolinium enhancement along the course of myocarditis.","volume":"39","author":"K\u00e1rolyi","year":"2023","journal-title":"Int J Cardiovasc Imaging"},{"issue":"3","key":"hoi260043r21","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1161\/CIRCIMAGING.111.963421","article-title":"Dynamic changes of edema and late gadolinium enhancement after acute myocardial infarction and their relationship to functional recovery and salvage index.","volume":"4","author":"Dall\u2019Armellina","year":"2011","journal-title":"Circ Cardiovasc Imaging"},{"issue":"3","key":"hoi260043r22","doi-asserted-by":"publisher","DOI":"10.1148\/ryct.240313","article-title":"Prognostic value of cardiovascular MRI in asymptomatic patients with moderate-to-severe aortic regurgitation: a network meta-analysis.","volume":"7","author":"Figliozzi","year":"2025","journal-title":"Radiol Cardiothorac Imaging"},{"issue":"4","key":"hoi260043r23","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jacc.2009.12.074","article-title":"Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease.","volume":"56","author":"Azevedo","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"hoi260043r24","doi-asserted-by":"publisher","first-page":"106","DOI":"10.14797\/mdcvj.964","article-title":"Cardiac magnetic resonance in valvular heart disease: assessment of severity and myocardial remodeling.","volume":"16","author":"Malahfji","year":"2020","journal-title":"Methodist Debakey Cardiovasc J"},{"issue":"3","key":"hoi260043r25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1001\/jama.2024.22730","article-title":"Early intervention in patients with asymptomatic severe aortic stenosis and myocardial fibrosis: the EVOLVED randomized clinical trial.","volume":"333","author":"Loganath","year":"2025","journal-title":"JAMA"},{"issue":"1","key":"hoi260043r26","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2014-000184","article-title":"Plasma brain natriuretic peptide concentrations in patients with valvular heart disease.","volume":"3","author":"Sharma","year":"2016","journal-title":"Open Heart"},{"issue":"7","key":"hoi260043r27","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1001\/jamasurg.2024.0718","article-title":"Placebo control and blinding in randomized trials of procedural interventions: a systematic review and meta-regression.","volume":"159","author":"Rajkumar","year":"2024","journal-title":"JAMA Surg"},{"issue":"1","key":"hoi260043r28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3904\/kjim.2003.18.1.35","article-title":"The role of cardiopulmonary exercise test in mitral and aortic regurgitation: it can predict post-operative results.","volume":"18","author":"Kim","year":"2003","journal-title":"Korean J Intern Med"},{"issue":"4","key":"hoi260043r29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1159\/000173870","article-title":"Determination of the anaerobic threshold in the evaluation of functional status before and following valve replacement for aortic regurgitation.","volume":"72","author":"Niemei\u00e4","year":"2008","journal-title":"Cardiology"},{"issue":"15","key":"hoi260043r30","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1016\/j.jacc.2023.02.036","article-title":"Timing for intervention in aortic regurgitation: when one does not fit all.","volume":"81","author":"Sannino","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"hoi260043r31","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3390\/diseases12080191","article-title":"Left ventricular reverse remodeling after surgical aortic valve replacement for aortic regurgitation-an explorative study.","volume":"12","author":"Arnold","year":"2024","journal-title":"Diseases"},{"key":"hoi260043r16","unstructured":"R Foundation for Statistical Computing. R: a language and environment for statistical computing. https:\/\/www.R-project.org\/"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2853334\/jamacardiology_thornton_2026_oi_260043_1790870207.45481.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T15:00:56Z","timestamp":1791990056000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2853334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2026.3204","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,1]]}}}